Probiotics for the treatment of inflammatory bowel disease

scientific article published on August 2012

Probiotics for the treatment of inflammatory bowel disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1018375817
P356DOI10.1007/S11894-012-0265-5
P698PubMed publication ID22581276

P2093author name stringJohn Betteridge
Patrick E Young
Ganesh R Veerappan
P2860cites workDevelopment of the human infant intestinal microbiotaQ21003936
Inflammatory Bowel DiseaseQ22248115
Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitisQ22251072
A frameshift mutation in NOD2 associated with susceptibility to Crohn's diseaseQ22251291
Probiotics for maintenance of remission in ulcerative colitisQ24234400
Interventions for prevention of post-operative recurrence of Crohn's diseaseQ24240542
Probiotics for induction of remission in Crohn's diseaseQ24242115
Probiotics for induction of remission in ulcerative colitisQ24242963
Probiotics for maintenance of remission in Crohn's diseaseQ24244110
Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient miceQ24523182
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazineQ24685766
Lactobacillus GG in inducing and maintaining remission of Crohn's diseaseQ24806098
Saccharomyces boulardii in maintenance treatment of Crohn's diseaseQ28144634
A pilot trial of Saccharomyces boulardii in ulcerative colitisQ28184581
Gut flora in health and diseaseQ28209082
The host-microbe interface within the gutQ28216971
Probiotic use in clinical practice: what are the risks?Q28245049
Unravelling the pathogenesis of inflammatory bowel diseaseQ29547551
New concepts in the pathophysiology of inflammatory bowel diseaseQ30438997
Assessment of Mucosal Inflammation and Circulation in Response to Probiotics in Patients Operated with Ileal Pouch Anal Anastomosis for Ulcerative ColitisQ30927782
Assessment of mucosal inflammation and blood flow in response to four weeks' intervention with probiotics in patients operated with a J-configurated ileal-pouch-anal-anastomosis (IPAA).Q33212468
Potential probiotic characteristics of Lactobacillus and Enterococcus strains isolated from traditional dadih fermented milk against pathogen intestinal colonizationQ33280100
Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)Q33557634
Colitis in transgenic and knockout animals as models of human inflammatory bowel diseaseQ33713331
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trialQ33872486
Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitisQ34192292
Pouchitis: result of microbial imbalance?Q34378691
Complementary and alternative medicine use by patients with inflammatory bowel disease: results from a postal surveyQ34499357
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trialQ34510060
Role of the faecal stream in the maintenance of Crohn's colitisQ34526492
Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG.Q34547390
A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's diseaseQ34560319
A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's diseaseQ34588311
Recommendations for probiotic use-2011 updateQ34632974
Probiotics, nuclear receptor signaling, and anti-inflammatory pathwaysQ35131051
Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.Q35233808
Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.Q35594940
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitisQ35596222
Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colonQ35598397
Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial.Q35760489
The bacteriology of pouchitis: a molecular phylogenetic analysis using 16S rRNA gene cloning and sequencingQ35799373
Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogensQ35890738
The role of enteric microflora in inflammatory bowel disease: human and animal studies with probiotics and prebiotics.Q36220431
Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practiceQ36273531
Production of experimental ulcerative colitis in gnotobiotic guinea pigs with simplified microfloraQ36422699
Clinical efficacy of probiotics: review of the evidence with focus on childrenQ36620391
Bacteria- and host-derived mechanisms to control intestinal epithelial cell homeostasis: implications for chronic inflammationQ36809889
Probiotics and remission of ulcerative colitis: a systematic reviewQ37031840
Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseasesQ37214848
Probiotics in the treatment of human inflammatory bowel diseases: update 2011.Q37944981
Prebiotics and probiotics: their role in the management of gastrointestinal disorders in adultsQ37962875
Real-time PCR quantification of bacterial adhesion to Caco-2 cells: competition between bifidobacteria and enteropathogensQ40396945
Effects of the faecal stream and stasis on the ileal pouch mucosaQ41813315
Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitroQ42282244
Antibiotics and probiotics in chronic pouchitis: a comparative proteomic approach.Q42945261
Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trialQ43363077
Mucosal flora in inflammatory bowel diseaseQ43503928
Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis.Q45126890
Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitisQ45166043
Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitisQ46143449
Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cellsQ47945739
Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot studyQ48677169
High dose probiotic and prebiotic cotherapy for remission induction of active Crohn's disease.Q53231256
Failure of Synbiotic 2000 to prevent postoperative recurrence of Crohn's diseaseQ57124109
Role of commercial probiotic strains against human pathogen adhesion to intestinal mucusQ58261045
VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative ColitisQ59120549
Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profilesQ59880418
Is Lactobacillus GG Helpful in Children With Crohn’s Disease? Results of a Preliminary, Open-Label StudyQ63285887
Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatmentQ72800631
Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial floraQ73092300
Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitisQ73837821
Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?Q74126152
Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileumQ74133428
Inflammatory bowel disease: lessons from the IL-10 gene-deficient mouseQ74625172
Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resectionQ79502910
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitisQ83333118
The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitisQ84290217
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectinflammationQ101991
inflammatory bowel diseasesQ917447
probioticsQ1816730
P304page(s)324-333
P577publication date2012-08-01
P1433published inCurrent gastroenterology reportsQ26842032
P1476titleProbiotics for the treatment of inflammatory bowel disease
P478volume14

Reverse relations

cites work (P2860)
Q37680765A phase one safety study of Lactobacillus reuteri conducted in the Peruvian Amazon: Observations from the field
Q41816719Actions of probiotics on trinitrobenzenesulfonic acid-induced colitis in rats
Q35688499Attenuation of Colitis by Lactobacillus casei BL23 Is Dependent on the Dairy Delivery Matrix
Q35134825Beneficial modulation of the gut microbiota.
Q57825805Biological Activities of Lactose-Derived Prebiotics and Symbiotic with Probiotics on Gastrointestinal System
Q28817192Can probiotics modulate human disease by impacting intestinal barrier function?
Q26768564Diet therapy for inflammatory bowel diseases: The established and the new
Q27330156Disturbance in the Mucosa-Associated Commensal Bacteria Is Associated with the Exacerbation of Chronic Colitis by Repeated Psychological Stress; Is That the New Target of Probiotics?
Q39249472Efficacy of Bifidobacterium breve NCC2950 against DSS-induced colitis is dependent on bacterial preparation and timing of administration
Q36830824Enteropathic spondyloarthritis: from diagnosis to treatment.
Q34716086Environment-related adaptive changes of gut commensal microbiota do not alter colonic toll-like receptors but modulate the local expression of sensory-related systems in rats.
Q26783044Gut Function-Enhancing Properties and Metabolic Effects of Dietary Indigestible Sugars in Rodents and Rabbits
Q26995672Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility
Q33801736Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission
Q34549031Gut microbiota, inflammation and colorectal cancer
Q28551430Highly Heterogeneous Probiotic Lactobacillus Species in Healthy Iranians with Low Functional Activities
Q34168490Infectious etiopathogenesis of Crohn's disease
Q52564079Inflammatory Bowel Disease and Immunonutrition: Novel Therapeutic Approaches Through Modulation of Diet and the Gut Microbiome.
Q64912397Intestinal Microbiome, Small Intestinal Bacterial Overgrowth and Inflammatory Bowel Diseases - What are the Connections?
Q35245299Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease
Q35018358Lactobacillus acidophilus alleviates platelet-activating factor-induced inflammatory responses in human intestinal epithelial cells
Q38130307Microbial activation of gut dendritic cells and the control of mucosal immunity
Q35195891Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation?
Q41313491Modulation of Gut Microbiome Composition and Function in Experimental Colitis Treated with Sulfasalazine
Q26772345Nutritional Keys for Intestinal Barrier Modulation
Q42216604Practical approaches to probiotics use.
Q29037475Probiotic Mix VSL#3 Is Effective Adjunctive Therapy for Mild to Moderately Active Ulcerative Colitis
Q44399817Probiotic therapy reduces periodontal tissue destruction and improves the intestinal morphology in rats with ligature-induced periodontitis
Q28087443Probiotics, prebiotics and synbiotics- a review
Q53542322Role of Faecalibacterium prausnitzii in Crohn's Disease: friend, foe, or does not really matter?
Q34407175Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?
Q28254207Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease
Q60959001The Dietary Intervention of Transgenic Low-Gliadin Wheat Bread in Patients with Non-Celiac Gluten Sensitivity (NCGS) Showed No Differences with Gluten Free Diet (GFD) but Provides Better Gut Microbiota Profile
Q35156014The multifaceted role of commensal microbiota in homeostasis and gastrointestinal diseases
Q35770445What colorectal surgeons should know about probiotics: a review

Search more.